Cherkasova Mariya V, Stoessl A Jon
J Clin Invest. 2014 Aug;124(8):3285-8. doi: 10.1172/JCI77193. Epub 2014 Jul 18.
Evaluation of potential therapies for neurological disease has been challenging due to beneficial responses in patients receiving the sham/placebo treatment. Placebo effects are especially prominent in Parkinson's disease (PD), which has become a useful model for studying the neurobiology of placebo responses. In this issue of the JCI, Ko and colleagues identify a neural circuit associated with the placebo response in a PD patient cohort. The observed placebo effect-associated pattern involved metabolic activity increases that corresponded with long-term motor improvements after sham surgery. Presurgery activity in this network was inversely related to sham response, suggesting that this network has potential for identifying sham responders and thus reducing placebo-related variance in surgical trials.
由于接受假手术/安慰剂治疗的患者出现有益反应,评估神经疾病的潜在治疗方法一直具有挑战性。安慰剂效应在帕金森病(PD)中尤为突出,该病已成为研究安慰剂反应神经生物学的有用模型。在本期《临床研究杂志》中,Ko及其同事在一组帕金森病患者中确定了与安慰剂反应相关的神经回路。观察到的与安慰剂效应相关的模式涉及代谢活动增加,这与假手术后的长期运动改善相对应。该网络术前的活动与假手术反应呈负相关,这表明该网络有可能识别假手术反应者,从而减少手术试验中与安慰剂相关的差异。